Figure 3
Figure 3. CD103hi iCD103-DCs develop independent of monocytes through Batf3- and Irf8-sensitive pathways and express CD8α/CD103 DC signature genes. (A) Relative expression of transcription factors by GM-DCs, FL-DCs, and iCD103-DCs. (B-C) iCD103-DCs generated from wild-type (WT) and (B) BXH2 (Irf8mut) or (C) Batf3−/− (Batf3KO) mice were analyzed by flow cytometry. The upper left plots show frequencies of CD11c+B220– cDCs and the lower left plots show frequencies of CD103hiClec9A+ DCs among cDCs (representative of 3 independent experiments). Quantifications of DC yields relative to WT cells are shown on the right for 3 independent experiments. NS, not statistically significant; **P < .01, ***P < .0001; paired Student t test. (D-E) GM-DCs, FL-DCs, and iCD103-DCs generated from LysM-Cre × Rosa26-RFP or Rosa26-RFP control mice (Ctrl) were analyzed for RFP expression by flow cytometry. One of 2 independent experiments, each involving 3 mice per genotype, is shown. (D) Representative plots compare CD11c vs RFP expression among CD11c+B220– BMDC subsets. (E) Summarized percentages of RFP+ DCs among CD11c+ GM-DCs, CD11c+B220–SIRPα– CD8α-like FL-DCs, CD11c+B220–SIRPα+ CD11b-like FL-DCs, CD11c+B220+ FL-pDCs, CD11c+B220–SIRPα+CD103– CD11b-like iCD103-DCs, and CD11c+B220–SIRPα–CD103hi CD8α-like iCD103-DCs. (F-H) Relative mRNA expression from FACS-sorted CD103hi and CD103– iCD103-DCs by Agilent microarray analysis. The expression of published gene signatures for pDCs, CD8+/CD103+ DCs, CD8– DCs, and macrophages was compared. See also supplemental Table 1. (F) Fraction of signature genes (black) upregulated ≥threefold in CD103+ vs CD103– iCD103-DCs (left; pDC: 4.3%, CD8+/CD103+: 82.1%, CD8–: 0%, MF: 0.9%) or upregulated ≥threefold in CD103– vs CD103+ iCD103-DCs (right; pDC: 32.3%, CD8+/CD103+: 0%, CD8–: 71.4%, MF: 47.4%). (G) Degree of overexpression (red) or underexpression (blue) for all genes of the CD8+/CD103+ DC signature in CD103+ vs CD103– iCD103-DCs (equal expression in white). (H) Signatures of pDCs, CD8– DCs, and macrophages as in (G). (I) Relative expression levels of Itgae, Tlr3, and Xcr1 among BMDCs. (J) GM-DCs or iCD103-DCs were stimulated for 24 hours with poly(inosine:cytidine) (pI:C) or CpG. IL-12/23p40 was quantified in the supernatant by enzyme-linked immunosorbent assay. Mean + SD (n = 3) is shown for 1 of 2 independent experiments. ND, not detectable. Data from (A) and (I) are combined from 2 independent experiments. Values are normalized to Hprt and GM-DCs.

CD103hi iCD103-DCs develop independent of monocytes through Batf3- and Irf8-sensitive pathways and express CD8α/CD103 DC signature genes. (A) Relative expression of transcription factors by GM-DCs, FL-DCs, and iCD103-DCs. (B-C) iCD103-DCs generated from wild-type (WT) and (B) BXH2 (Irf8mut) or (C) Batf3−/− (Batf3KO) mice were analyzed by flow cytometry. The upper left plots show frequencies of CD11c+B220 cDCs and the lower left plots show frequencies of CD103hiClec9A+ DCs among cDCs (representative of 3 independent experiments). Quantifications of DC yields relative to WT cells are shown on the right for 3 independent experiments. NS, not statistically significant; **P < .01, ***P < .0001; paired Student t test. (D-E) GM-DCs, FL-DCs, and iCD103-DCs generated from LysM-Cre × Rosa26-RFP or Rosa26-RFP control mice (Ctrl) were analyzed for RFP expression by flow cytometry. One of 2 independent experiments, each involving 3 mice per genotype, is shown. (D) Representative plots compare CD11c vs RFP expression among CD11c+B220 BMDC subsets. (E) Summarized percentages of RFP+ DCs among CD11c+ GM-DCs, CD11c+B220SIRPα CD8α-like FL-DCs, CD11c+B220SIRPα+ CD11b-like FL-DCs, CD11c+B220+ FL-pDCs, CD11c+B220SIRPα+CD103 CD11b-like iCD103-DCs, and CD11c+B220SIRPαCD103hi CD8α-like iCD103-DCs. (F-H) Relative mRNA expression from FACS-sorted CD103hi and CD103 iCD103-DCs by Agilent microarray analysis. The expression of published gene signatures for pDCs, CD8+/CD103+ DCs, CD8 DCs, and macrophages was compared. See also supplemental Table 1. (F) Fraction of signature genes (black) upregulated ≥threefold in CD103+ vs CD103 iCD103-DCs (left; pDC: 4.3%, CD8+/CD103+: 82.1%, CD8: 0%, MF: 0.9%) or upregulated ≥threefold in CD103 vs CD103+ iCD103-DCs (right; pDC: 32.3%, CD8+/CD103+: 0%, CD8: 71.4%, MF: 47.4%). (G) Degree of overexpression (red) or underexpression (blue) for all genes of the CD8+/CD103+ DC signature in CD103+ vs CD103 iCD103-DCs (equal expression in white). (H) Signatures of pDCs, CD8 DCs, and macrophages as in (G). (I) Relative expression levels of Itgae, Tlr3, and Xcr1 among BMDCs. (J) GM-DCs or iCD103-DCs were stimulated for 24 hours with poly(inosine:cytidine) (pI:C) or CpG. IL-12/23p40 was quantified in the supernatant by enzyme-linked immunosorbent assay. Mean + SD (n = 3) is shown for 1 of 2 independent experiments. ND, not detectable. Data from (A) and (I) are combined from 2 independent experiments. Values are normalized to Hprt and GM-DCs.

Close Modal

or Create an Account

Close Modal
Close Modal